Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Report on possible improvements for cancer screening published in Sweden

In June 2022, the National Board of Health and Welfare published the report "Towards a more coordinated cancer screening". The Government commissioned the assignment to develop a plan to improve cancer screening to the National Board of Health and Welfare, jointly with Regional Cancer Centers (RCC).

The National Board of Health and Welfare reported on measures taken to improve coordination in the cancer screening field and a number of proposals aimed to achieve a more equal and effective cancer screening. For example, a model for the national evaluation of screening programs was developed based on the model for evaluating the national guidelines; the Research Institutes of Sweden (RISE) was commissioned to assess cancer screening with liquid biopsies so that the National Board could decide on the introduction.

See more details in Swedish here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). First EU issues of both newsletters are available for download free-of-charge.

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).